Uppsala, Sweden – February 17, 2020. The board of Orexo AB (publ.) has resolved, pursuant to the authorisation granted by the annual general meeting held on 11 April 2019, to initiate a repurchase program of ordinary shares. The repurchases may comprise a maximum of 500,000 shares. Acquisitio... read more

Lund, Sweden, 17:00 PM CET, 12 February 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its management team. Patrick O'Donnell will leave BONESUPPORT and his role as General Manager & Executive Vice President Commercial ... read more

Lund, Sweden, 12:00 pm CET, 31 January 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has signed an agreement with Skandinaviska Enskilda Banken (SEB) for a credit facility of up to SEK 60 million. The credit line ... read more

BOSTON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FD... read more

Strong fundamentals in place to fuel strategy for future growth Q4 2019 highlights Total net revenues of SEK 238.1 million (227.1), up 4.8 percent Zubsolv® US net revenues of SEK 190.5 million (166.7), up 14.3 percent in SEK and 7.5 percent in local currency Net earnings of SEK 38... read more